AVBP
Price
$20.86
Change
-$1.04 (-4.75%)
Updated
Jan 16 closing price
Capitalization
861.13M
67 days until earnings call
Intraday BUY SELL Signals
JANX
Price
$13.76
Change
+$0.04 (+0.29%)
Updated
Jan 16 closing price
Capitalization
827.63M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVBP vs JANX

Header iconAVBP vs JANX Comparison
Open Charts AVBP vs JANXBanner chart's image
ArriVent BioPharma
Price$20.86
Change-$1.04 (-4.75%)
Volume$423.38K
Capitalization861.13M
Janux Therapeutics
Price$13.76
Change+$0.04 (+0.29%)
Volume$1.76M
Capitalization827.63M
AVBP vs JANX Comparison Chart in %
AVBP
Daily Signal:
Gain/Loss:
JANX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVBP vs. JANX commentary
Jan 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and JANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 19, 2026
Stock price -- (AVBP: $20.86 vs. JANX: $13.76)
Brand notoriety: AVBP and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 105% vs. JANX: 79%
Market capitalization -- AVBP: $861.13M vs. JANX: $827.63M
AVBP [@Biotechnology] is valued at $861.13M. JANX’s [@Biotechnology] market capitalization is $827.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 1 FA rating(s) are green whileJANX’s FA Score has 1 green FA rating(s).

  • AVBP’s FA Score: 1 green, 4 red.
  • JANX’s FA Score: 1 green, 4 red.
According to our system of comparison, AVBP is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 5 TA indicator(s) are bullish while JANX’s TA Score has 4 bullish TA indicator(s).

  • AVBP’s TA Score: 5 bullish, 5 bearish.
  • JANX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AVBP is a better buy in the short-term than JANX.

Price Growth

AVBP (@Biotechnology) experienced а +1.66% price change this week, while JANX (@Biotechnology) price change was -2.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

AVBP is expected to report earnings on Mar 26, 2026.

JANX is expected to report earnings on Mar 06, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVBP($861M) and JANX($828M) have the same market capitalization . AVBP YTD gains are higher at: 3.678 vs. JANX (-0.290). JANX has higher annual earnings (EBITDA): -142.22M vs. AVBP (-162.42M). JANX has more cash in the bank: 989M vs. AVBP (300M). AVBP has less debt than JANX: AVBP (56K) vs JANX (22.7M). JANX has higher revenues than AVBP: JANX (10M) vs AVBP (0).
AVBPJANXAVBP / JANX
Capitalization861M828M104%
EBITDA-162.42M-142.22M114%
Gain YTD3.678-0.290-1,269%
P/E RatioN/AN/A-
Revenue010M-
Total Cash300M989M30%
Total Debt56K22.7M0%
TECHNICAL ANALYSIS
Technical Analysis
AVBPJANX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 26 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signal:
Gain/Loss:
JANX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYPCX21.810.17
+0.79%
Nomura Systematic Emerging Markets Eq R
VWYKX50.970.23
+0.45%
Voya Small Cap Growth W
CMCIX25.79-0.02
-0.08%
Calvert Small/Mid-Cap I
CSQCX7.91-0.01
-0.13%
Calvert Global Small-Cap Equity C
PLCGX15.91-0.04
-0.25%
Principal LargeCap Growth I R6

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with VIR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-4.75%
VIR - AVBP
51%
Loosely correlated
-2.26%
CRNX - AVBP
49%
Loosely correlated
-0.78%
ELVN - AVBP
48%
Loosely correlated
+6.12%
XNCR - AVBP
48%
Loosely correlated
-3.18%
SYRE - AVBP
47%
Loosely correlated
+0.45%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with AVBP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then AVBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+0.29%
AVBP - JANX
43%
Loosely correlated
-4.75%
SKYE - JANX
41%
Loosely correlated
+3.89%
VIR - JANX
40%
Loosely correlated
-2.26%
UPB - JANX
39%
Loosely correlated
+0.32%
CGON - JANX
37%
Loosely correlated
+3.13%
More